Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab.
about
Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease.Correlation between STK33 and the pathology and prognosis of lung cancer.Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer.Radium and other alpha emitters in prostate cancer
P2860
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@ast
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@en
type
label
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@ast
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@en
prefLabel
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@ast
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@en
P2093
P2860
P1476
Targeted α-Particle Radiation ...... oclonal Antibody, Panitumumab.
@en
P2093
Diane E Milenic
Kwamena E Baidoo
Martin W Brechbiel
Rachel Barkley
Young-Seung Kim
P2860
P304
P356
10.1016/J.TRANON.2017.04.004
P577
2017-05-31T00:00:00Z